Cough asthma, formally called cough-variant asthma (CVA), is a type of asthma where a persistent dry cough is the only symptom. Unlike classic asthma, it doesn’t cause wheezing or shortness of breath, which is exactly why it often goes undiagnosed for months or years. It accounts for an estimated 25% to 42% of all chronic cough cases, making it the single most common cause of a cough that won’t go away.
How It Differs From Classic Asthma
In classic asthma, the airways narrow enough to produce audible wheezing and make breathing feel tight. Cough-variant asthma involves the same underlying problem, airway hyperresponsiveness, but the narrowing is subtler. Your airways are irritable and reactive, but not so constricted that you wheeze. Instead, the inflammation triggers the cough reflex as the dominant response.
About 61% of people with cough-variant asthma also have dysfunction in the smaller, deeper branches of their airways. Those who do tend to have a longer-lasting cough and somewhat worse overall lung function, even though they still don’t wheeze. This is one reason the condition can feel frustrating: lung function tests at a routine checkup may look relatively normal, yet the cough persists.
What the Cough Feels Like
The hallmark is a dry, nonproductive cough, though some people do cough up mucus. It comes in episodes or attacks that can last hours or even days, often worse at night. Between episodes you may feel completely fine, which adds to the confusion.
The most common triggers are:
- Cold air
- Weather changes
- Exercise
A cough lasting more than eight weeks in an adult is considered chronic. If you’ve hit that mark and no one has identified a cause, cough-variant asthma is one of the first possibilities worth investigating.
Why It’s Hard to Diagnose
Because there’s no wheezing or obvious breathing difficulty, cough-variant asthma is easily mistaken for other common causes of chronic cough. The three conditions that most frequently overlap or get confused are acid reflux, upper airway cough syndrome (postnasal drip), and a condition called eosinophilic bronchitis.
Acid reflux cough typically worsens after meals and comes with throat irritation or a sour taste. Upper airway cough syndrome usually involves nasal congestion, a runny nose, or the sensation of mucus dripping down the back of your throat. If those features are absent, the likelihood shifts toward cough-variant asthma. Eosinophilic bronchitis can look very similar on the surface, but a key distinction is that it doesn’t involve the exaggerated airway reactivity that defines asthma.
The most definitive test is a bronchial provocation challenge. You inhale a substance that mildly constricts the airways, and a technician measures how your lungs respond. In someone with cough-variant asthma, the airways will overreact at a low dose. Standard breathing tests (spirometry) often come back normal in CVA, which is precisely why the provocation test is needed. If your doctor suspects CVA but spirometry looks fine, that doesn’t rule it out.
Treatment and What to Expect
Cough-variant asthma responds to the same treatments as classic asthma. Inhaled corticosteroids, delivered through a daily inhaler, are the first-line therapy. These reduce the underlying airway inflammation that drives the cough. Most people notice improvement within a few weeks, though it can take longer.
If the cough doesn’t fully resolve with an inhaled corticosteroid alone, the next step is usually adding a second medication. Options include a long-acting bronchodilator (combined with the corticosteroid in a single inhaler) or a leukotriene receptor antagonist, a daily pill that blocks a different part of the inflammatory pathway. Studies show that adding the leukotriene blocker to an inhaled corticosteroid provides meaningful additional relief for people whose cough is only partially controlled.
One of the most important things to understand about treatment is that stopping it too early is risky. Long-term, consistent use of the inhaler matters, not just for symptom control but for preventing the condition from worsening.
Risk of Progressing to Classic Asthma
Left untreated, cough-variant asthma progresses to full classic asthma, with wheezing and breathing difficulty, in 30% to 40% of adults. In children, the rate may be even higher. This is not a minor risk, and it’s the strongest argument for staying on treatment even after the cough improves.
Treatment significantly cuts this progression rate. In a prospective study that followed patients on inhaled corticosteroids for two years, only 15% developed classic asthma, roughly half the rate seen in untreated groups. A separate analysis found that not using an inhaled corticosteroid was the single strongest predictor of whether someone’s CVA would evolve into classic asthma. In practical terms, the daily inhaler isn’t just suppressing a cough. It’s protecting your airways from permanent changes that make the disease harder to manage later.
Cough-Variant Asthma in Children
Children with cough-variant asthma present the same way adults do: a chronic dry cough, often triggered by cold air or exercise, without wheezing. The diagnostic challenge is greater in young children because they may not be able to perform the breathing tests reliably. Doctors often rely on a therapeutic trial instead, prescribing asthma medication and watching whether the cough resolves. If it does, that strongly supports the diagnosis.
Because children face a higher risk of progression to classic asthma, consistent treatment once the diagnosis is established is especially important. Parents sometimes stop the inhaler once the cough disappears, but the inflammation can persist silently even when symptoms are gone.